Publication Name	World Journal of Gastroenterology
Manuscript ID	16501
Country	Taiwan

Received	2015-01-20 17:59
Peer-Review Started	2015-01-21 21:12
To Make the First Decision	2015-02-10 15:30
Return for Revision	2015-02-12 14:08
Revised	2015-04-12 15:06
Second Decision	2015-07-03 20:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-07-08 17:10
Articles in Press	2015-07-08 17:10
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-08-18 11:06
Typeset the Manuscript	2015-09-07 15:33
Publish the Manuscript Online	2015-09-28 11:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Prospective Study
Article Title	Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: a prospective randomized trial
Manuscript Source	Unsolicited Manuscript
All Author List	Kuan-Yang Chen, Tsung-Jung Lin, Chin-Lin Lin, Hsi-Chang Lee, Chung-Kwe Wang and Deng-Chyang Wu
Funding Agency and Grant Number
Corresponding Author	Hsi-Chang Lee, MD, Liver Center, Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, No. 10, Sec4 Ren-Ai Rd, Da-An Dist, Taipei City 10629, Taiwan. dab73@tpech.gov.tw
Key Words	Helicobacter pylori; Sequential therapy; Hybrid therapy
Core Tip	The ideal therapy regimen for Helicobacter pylori (H. pylori) infection should achieve an eradication rate ≥ 90% on per-protocol analysis. Both the hybrid and sequential therapies have shown eradication rates superior to the standard triple therapy in several studies. To the best of our knowledge, this is the first study on the comparison between hybrid therapy and sequential therapy in Taiwan population. Hybrid regimen is a more effective therapy for H. pylori eradication than sequential regimen.
Publish Date	2015-09-28 11:42
Citation	Chen KY, Lin TJ, Lin CL, Lee HC, Wang CK, Wu DC. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: a prospective randomized trial. World J Gastroenterol 2015; 21(36): 10435-10442
URL	http://www.wjgnet.com/1007-9327/full/v21/i36/10435.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i36.10435

Full Article (PDF)	WJG-21-10435.pdf
Full Article (Word)	WJG-21-10435.doc
Manuscript File	16501-Review.docx
Answering Reviewers	16501-Answering reviewers.pdf
Audio Core Tip	16501-Audio core tip.mp3
Biostatistics Review Certificate	16501-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	16501-Conflict-of-interest statement.pdf
Copyright License Agreement	16501-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	16501-Institutional review board statement.pdf
Peer-review Report	16501-Peer-review(s).pdf
Scientific Misconduct Check	16501-Scientific misconduct check.pdf
Scientific Editor Work List	16501-Scientific editor work list.pdf